What does hCG do? Benefits and evidence
A fertility hormone with limited testosterone add-on evidence and no proven weight-loss benefit.
Also called: human chorionic gonadotropin, human chorionic gonadotrophin, chorionic gonadotropin, choriogonadotropin alfa, Pregnyl, Novarel, Ovidrel, Ovitrelle.
Reproductive axis peptides · LH/chorionic gonadotropin receptor agonist; glycoprotein hormone · Evidence: Approved drug.
hCG stimulates the testes or ovaries and is approved for selected fertility uses. Small studies during testosterone therapy do not guarantee sperm production or pregnancy, and weight-loss benefit is unproven. It acts through the luteinizing hormone receptor. Risks include hormone-related effects and ovarian hyperstimulation.
- hCG is approved for some men with low testosterone from weak brain hormone signals, and to help women ovulate. (Drug label)
- Ovidrel is approved to trigger final egg maturation during fertility treatment. (Drug label)
- In small studies of men on testosterone therapy, hCG helped preserve the testes' own testosterone and semen, but fertility was not proven. (Studied in a trial)
- Men on testosterone therapy report fuller testes or better sexual symptoms. (Reported by users)
Uses in the sources
- Urinary hCG is approved for selected male hypogonadotropic hypogonadism and ovulation induction. (Drug label) (source)
- Recombinant hCG is approved to trigger final egg maturation after ovarian stimulation. (Drug label) (source)
- Clinicians publish off-label TRT add-on and sperm-recovery regimens. Evidence remains limited. (Clinician-published) (source)
Related to hCG
- Kisspeptin-10: A short-acting experimental peptide that triggers reproductive hormone release.
- Gonadorelin: A short-acting fertility hormone used in tests and specialist pump therapy.
Sources
- Compounding and the FDA: Questions and Answers, FDA · FDA · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026, Australian Government · Australian Government · 2026
- NOVAREL- gonadotrophin, chorionic kit, Ferring · 2025
- Ovitrelle, European Medicines Agency · 2025
- Ovitrelle, INN-choriogonadotropin alfa, European Medicines Agency · 2025
- Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline (2020; Amended 2024), AUA/ASRM · 2024
- OVIDREL- choriogonadotropin alfa injection, solution, EMD Serono · 2023
- Notice to Compounders: Changes that affect compounding as of March 23, 2020, FDA · 2020
- Avoid Dangerous HCG Diet Products, FDA
- Ovitrelle 250 micrograms/0.5 mL solution for injection in pre-filled syringe, Merck
- PREGNYL- choriogonadotropin alfa kit, Organon
- Product information, Health Canada
- Pituitary Axis Impacts and Effectiveness of Clomiphene and Human Chorionic Gonadotropin in Treating Hypogonadism: Cohort Study., Clift AK et al. · The world journal of men's health · 2026
- Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men., Clift AK et al. · The world journal of men's health · 2026
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.